Inventa Capital is a biotech-focused investment firm that leverages operational expertise and scientific insight to unlock value in overlooked companies. We specialize in restructuring and strategic repositioning, targeting exits through M&A or IPO. Our mission is to transform undervalued innovation into meaningful investor returns with speed and precision.